Form 8-K - Current report:
SEC Accession No. 0001437749-26-020980
Filing Date
2026-06-17
Accepted
2026-06-17 16:29:56
Documents
13
Period of Report
2026-06-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20260617c_8k.htm   iXBRL 8-K 30514
2 EXHIBIT 4.1 ex_978162.htm EX-4.1 102813
  Complete submission text file 0001437749-26-020980.txt   287207

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sdev-20260612.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sdev-20260612_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sdev-20260612_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sdev-20260612_pre.xml EX-101.PRE 11584
16 EXTRACTED XBRL INSTANCE DOCUMENT nby20260617c_8k_htm.xml XML 2858
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
Stablecoin Development Corp (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 261098905
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)